Jul 10, 2024, 02:42
Charlotte Davison: Myricx Bio has joined the British Patient Capital portfolio
Charlotte Davison, Board Observer at
“Absolutely thrilled to share that Myricx Bio has joined the British Patient Capital portfolio. We are delighted to have participated in this £90m Series A funding to accelerate development of their novel NMTi ADC platform towards clinic.
It’s been a pleaseure to work with Novo Holdings, Abingworth, Eli Lilly and Company, Sofinnova Partners and Brandon Capital along with a stellar team (Robin Carr, Julie Mead, Francesca Zammarchi) to pull this round together.
Congratulations all! ”